CDT (006)

External quality assessment for carbohydrate deficient transferrin (CDT ). The test material consists of two samples of pooled human sera with varying concentrations of CDT. It is not tested for infectious diseases.

The purpose of the scheme is to provide participating laboratories with the opportunity to evaluate their performance in CDT analysis by comparing results with those from other laboratories and monitoring analysis quality over time.

The scheme is aimed for clinical laboratories that analyze CDT.

Frequency: 6/year

Reports: Normally within one month from closing date.

Swedish laboratories register on our Swedish site. Laboratories from Denmark, Finland or Norway register through their national distributors, DEKS (Denmark), Aurevia (Finland) or Noklus (Norway). Laboratories from other countries register through Aurevia, our distributor outside Scandinavia. Please, note that the scheme may not be available in all countries.